Malignancies associated with brachytherapy for prostate cancer are largely unreported in the literature. We report a case of post-brachytherapy osteogenic sarcoma in the pelvis 6 years after permanent 125I implant for intermediate-risk prostate cancer. The patient was treated with neoadjuvant chemotherapy, limb-sparing surgical resection and postoperative radiation therapy for unexpected positive margins.
Ye AY, Conway J, Peacock M, Clarkson PW, Lee CH, Simmons C, Weir L, McKenzie M. Are you the author?
Department of Radiation Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency, Vancouver, BC; Department of Orthopedics, University of British Columbia, Vancouver, BC; Department of Laboratory Medicine and Pathology, University of Alberta and Royal Alexandra Hospital, Edmonton, AB; Department of Medical Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency, Vancouver, BC.
Reference: Can Urol Assoc J. 2014 May;8(5-6):E468-70.